More News

08 Dec 2020 Maze Therapeutics and Alloy Therapeutics Form Broadwing Bio to Develop Antibody Therapies for Genetically Validated Targets in Ophthalmic Diseases
04 Dec 2020 Tevard Biosciences and Zogenix Announce Collaboration to Advance Novel Gene Therapies for Dravet Syndrome and Other Genetic Epilepsies
04 Dec 2020 PharmaEngine, Inc. and Sentinel Oncology Limited Enter into an Exclusive Collaboration and License Agreement for SOL-578, a Chk1 inhibitor
03 Dec 2020 Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
03 Dec 2020 Bayer establishes Cell and Gene Therapy Platform to accelerate pharmaceutical innovation
02 Dec 2020 AbbVie and Frontier Medicines Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets
01 Dec 2020 Casma Therapeutics and Vipergen Enter Into Drug Discovery Agreement
01 Dec 2020 Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies
01 Dec 2020 Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement
01 Dec 2020 Sosei Heptares and Biohaven Enter Global Collaboration and License Agreement to Advance Novel Small-Molecule CGRP Antagonist Portfolio
28 Nov 2020 Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
23 Nov 2020 Creation of a research partnership between Pierre Fabre and Y-Biologics for the development of new immunotherapies based on monoclonal antibodies
23 Nov 2020 Schrödinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibb
23 Nov 2020 Horizon Therapeutics plc and Halozyme Therapeutics, Inc. Enter Global Collaboration and License Agreement for ENHANZE® Technology
23 Nov 2020 Merck to Acquire OncoImmune
20 Nov 2020 Lilly and Precision BioSciences Announce Genome Editing Research Collaboration and License Agreement
19 Nov 2020 ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease
19 Nov 2020 Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetes
18 Nov 2020 Caribou Biosciences Announces Licensing Agreement for scFvs Targeting CD371 to Enable Development of Allogeneic Cell Therapies
16 Nov 2020 Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases
13 Nov 2020 BeyondSpring Subsidiary, Seed Therapeutics, Announces Research Collaboration and License Agreement with Lilly
12 Nov 2020 MorphoSys and Cherry Biolabs Announce licensing of Hemibody Technology
09 Nov 2020 Infinity Pharmaceuticals Presents New MARIO-1 Phase 1/1b Clinical Data at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting
06 Nov 2020 OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosis
06 Nov 2020 Artiva Biotherapeutics and Affimed Announce Platform-to-Platform R&D Collaboration for Targeted Off-the-Shelf NK Cell Therapies

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up